Actively Recruiting
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Led by Biotheus Inc. · Updated on 2024-12-05
380
Participants Needed
48
Research Sites
246 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is to characterize the safety, tolerability, pharmacokinetics (PK), immunogenicity, pharmacodynamics (PD) and anti-tumor activity of PM8002, a PD-L1/VEGF bispecific antibody, as a single agent in adult subjects with advanced solid tumors.
CONDITIONS
Official Title
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary participation with informed consent and ability to complete all study procedures
- Male or female aged 18 to 75 years
- Histologically or cytologically confirmed malignant tumor
- Toxicity from previous anti-tumor therapy not alleviated
- Adequate organ function
- ECOG performance status of 0 to 1
- Expected survival of at least 12 weeks
- At least one measurable lesion not previously treated locally per RECIST 1.1 criteria
You will not qualify if you...
- History of severe allergic disease or known allergy to study drug components
- Major coagulopathy or significant bleeding risk
- Active interstitial lung disease or non-infectious pneumonia, unless caused by local radiotherapy
- Uncontrolled brain metastases
- Other active malignant tumors within 5 years prior to treatment
- Prior allogeneic organ or hematopoietic stem cell transplantation
- History of alcohol, psychotropic drug, or drug abuse
- Positive for syphilis antibody
- Active tuberculosis
- Pregnant or lactating women
- Any other condition making participation inappropriate as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 48 locations
1
Baoji Central Hospital
Baoji, China
Actively Recruiting
2
Baoji Central Hospital
Baoji, China
Actively Recruiting
3
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Actively Recruiting
4
Peking University Cancer Hospital
Beijing, China
Actively Recruiting
5
Peking University Cancer Hospital
Beijing, China
Actively Recruiting
6
Jilin Cancer Hospital
Changchun, China
Actively Recruiting
7
The First Hospital of Jilin University
Changchun, China
Actively Recruiting
8
Changde First People's Hospital
Changde, China
Actively Recruiting
9
Hunan Provincial People's Hospital
Changsha, China
Actively Recruiting
10
The First People's Hospital of Changzhou
Changzhou, China
Actively Recruiting
11
Chengdu Integrated TCM& Western Medicine Hospital
Chengdu, China
Actively Recruiting
12
Sichuan Cancer Hospital
Chengdu, China
Actively Recruiting
13
Chongqing Cancer Hospital
Chongqing, China
Actively Recruiting
14
Chongqing Cancer Hospital
Chongqing, China
Actively Recruiting
15
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
Actively Recruiting
16
The Southwest Hospital of AMU
Chongqing, China
Actively Recruiting
17
Fujian Cancer Hospital
Fuzhou, China
Actively Recruiting
18
Fujian Cancer Hospital
Fuzhou, China
Actively Recruiting
19
Zhejiang Provincial People's Hospital
Hangzhou, China
Actively Recruiting
20
Harbin Medical University Cancer Hospital
Harbin, China
Actively Recruiting
21
Anhui Provincial Hospital
Hefei, China
Actively Recruiting
22
Linyi Cancer Hospital
Linyi, China
Actively Recruiting
23
Jiangsu Province Hospital
Nanjing, China
Actively Recruiting
24
Jiangsu Province Hospital
Nanjing, China
Actively Recruiting
25
Shanghai Orient Hospital
Shanghai, China
Actively Recruiting
26
Shanghai Sixth People's Hospital
Shanghai, China
Actively Recruiting
27
Shengjing Hospital of China Medical University
Shengjing, China
Actively Recruiting
28
Liaoning Cancer Hospital
Shenyang, China
Actively Recruiting
29
The First Hospital of China Medical University
Shenyang, China
Actively Recruiting
30
The People's Hospital of Liaoning Province
Shenyang, China
Actively Recruiting
31
The Fourth Hospital of Hebei Medical University
Shijiazhuang, China
Actively Recruiting
32
Shanxi Bethune Hospital
Taiyuan, China
Actively Recruiting
33
Shanxi Provincial Cancer Hospital
Taiyuan, China
Actively Recruiting
34
Shanxi Provincial Cancer Hospital
Taiyuan, China
Actively Recruiting
35
Taizhou Hospital of Zhejiang Province
Taizhou, China
Actively Recruiting
36
The Second Hospital of Tianjin Medical University
Tianjin, China
Actively Recruiting
37
Hubei Cancer Hospital
Wuhan, China
Actively Recruiting
38
Hubei Cancer Hospital
Wuhan, China
Actively Recruiting
39
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China
Actively Recruiting
40
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
Actively Recruiting
41
Xi 'an International Medical Center Hospital
Xi'an, China
Actively Recruiting
42
Xi 'an International Medical Center Hospital
Xi'an, China
Actively Recruiting
43
Yantai Yuhuangding Hospital
Yantai, China
Actively Recruiting
44
Yibin Second People's Hospital
Yibin, China
Actively Recruiting
45
Henan Cancer Hospital
Zhengzhou, China
Actively Recruiting
46
The first affilated hospital of zhengzhou university
Zhengzhou, China
Actively Recruiting
47
The first affilated hospital of zhengzhou university
Zhengzhou, China
Actively Recruiting
48
Zhujiang Hospital of Southern Medical University
Zhujiang, China
Actively Recruiting
Research Team
Y
Ye Guo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here